REGN
NASDAQ NMS - GLOBAL MARKETUSRegeneron Pharmaceuticals, Inc.
Biotechnology
$945.53USD
▼ 12.23 (1.28%)
● Live
Key Metrics
Revenue TTM
$16.55B
Profit Margin
28.51%
EPS (TTM)
$45.28
52-Week High
$991.73
52-Week Low
$591.52
P/E Ratio
20.56
Forward P/E
13.76
ROE
15.07%
Debt / Equity
0.08×
Market Cap
$97.80B
Athena Intelligence
● AnalyzingAthena AI Model v1.0
Athena Intelligence
Analyzing REGN
Reading financial statements●
Evaluating profitability metrics
Scanning market sentiment
Analyzing valuation multiples
Building investment thesis
52-Week Range
$591.52
$991.73
52W LowCurrent: $945.53 (88.5% of range)52W High